𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for Type 2 diabetes

✍ Scribed by Deacon, Carolyn F

Book ID
125535685
Publisher
Informa plc
Year
2007
Tongue
English
Weight
194 KB
Volume
16
Category
Article
ISSN
1354-3784

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Type 2 diabetesβ€”Therapy with dipeptidyl
Type 2 diabetesβ€”Therapy with dipeptidyl peptidase IV inhibitors
✍ Hans-Ulrich Demuth; Christopher H.S. McIntosh; Raymond A. Pederson πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 803 KB

The sole application of an inhibitor of the dipeptidyl peptidase DP IV (also DP 4, CD26, DPP-IV or DPP-4) to a mammal subsequently leading to improved glucose tolerance marks a major breakthrough in metabolic research bearing the potential of a new revolutionary diabetes therapy. This was demonstrat